WOBURN, Mass., Sept. 27, 2024 /PRNewswire/ -- ProTom
International, a leading provider of compact proton therapy
technology that is transforming cancer treatment, is pleased to
introduce its new proton therapy system, the Radiance 330-C Proton
Therapy SystemTM.
This new compact, fixed-beam room configuration is a modular and
economically viable proton therapy solution, enabling healthcare
providers to develop single or multiple-room capabilities within or
adjacent to existing Linac vaults in radiation oncology
departments. When integrated with Leo
Cancer Care's upright patient positioning and imaging
system, Radiance 330-C will extend the offering of gantry-less
proton therapy without sacrificing treatment capability to the
industry, while reducing costs and increasing the flexibility of
proton therapy centers.
The system features Fidelity™ pencil beam scanning technology
offering superior dose sculpting, an upright patient positioning
system and diagnostic quality CT at the treatment isocenter which
will enable real-time adaptive therapy. The stationary beam
delivery system improves reliability, beam parameters, and accuracy
while reducing maintenance costs. Additionally, it includes a
compact synchrotron particle accelerator that delivers a clinical
treatment energy range from 70 MeV to 250 MeV with a capacity of up
to 330 MeV for future deployment of proton imaging.
Paul Tso, CEO of ProTom comments:
"ProTom is thrilled to introduce Radiance 330-C to the world. With
Leo's Upright Positioning and imaging System, Radiance 330-C
becomes even more accessible to those who need it but are
constrained by space and resources. As ProTom promised, we are
dedicated to providing healthcare providers with a modular,
compact, and economically viable proton therapy solution. With this
new compact proton therapy system, we can better achieve our
goal."
Stephen Towe, CEO of Leo Cancer Care shares similar sentiments: "Our
mission has always been to bring Proton Therapy to as many people
as possible. Making our solution available in as many
configurations as possible is an important step to achieve this.
This partnership with ProTom International signifies the industry's
willingness to innovate and breakdown existing barriers to better
care."
*The Radiance 330-C Proton Therapy System is not yet
available for clinical use.
About ProTom
ProTom International is a leading device manufacturer
of proton therapy technology. Combined with the fast
return on investment and the precision of pencil beam scanning and
the power of integrated imaging, ProTom's Radiance 330-C
proton therapy system is the choice for future proton therapy
technology.
For more information, please
visit: https://protominternational.com/radiance-330-c
Contact us: https://protominternational.com/contact
Press contact: 383874@email4pr.com
Find us on LinkedIn
View original content to download
multimedia:https://www.prnewswire.com/news-releases/protom-international-introduces-radiance-330-c-a-more-flexible-and-accessible-proton-therapy-solution-302260588.html
SOURCE ProTom International